Yale AI flags heart failure risk from a simple ECG photo
Yale School of Medicine researchers just built an AI tool that predicts future heart failure risk using standard 12-lead ECG images. The model was successfully validated across patient populations in the US, UK, and Brazil, giving doctors a low-cost screening method well before overt symptoms show up.

Every routine physical includes an ECG: you lie still for two minutes, sticky pads go on your chest, and a machine spits out a strip of squiggly lines. Your doctor usually glances at it, checks for an active rhythm issue, and files it away.
Researchers at Yale School of Medicine think that humble paper strip can predict your future.
A team led by Yale’s Cardiovascular Data Science (CarDS) Lab just published a study in the European Heart Journal introducing an AI model that can spot individuals at high risk of developing future heart failure using just images of standard 12-lead electrocardiograms.
Reading between the lines of a photo
Heart failure affects millions worldwide, but catching it early is notoriously hard.
Right now, figuring out who is headed toward heart failure requires a battery of clinical work: deep medical histories, physical exams, and specialized blood panels. In under-resourced clinics, half of those tools simply aren’t available.
ECGs, on the other hand, are cheap, noninvasive, and practically everywhere.
According to first author Lovedeep Singh Dhingra, Yale's model takes a simple photo or scan of a 12-lead ECG and accurately flags future heart failure risk well before patients develop overt symptoms.
It does not require raw digital waveform data from proprietary hospital monitors. An image snapped from a standard printout is enough.
Tested across three continents
One big headache with medical AI is dataset bias: an algorithm trained in Boston often stumbles when deployed in London or São Paulo.
To prove generalizability, senior author Rohan Khera and his team validated the tool across diverse populations in the United States, the United Kingdom, and Brazil.
The multinational testing showed that the model remained accurate across different patient demographics and healthcare settings.
The project was backed by grants from the NIH’s National Heart, Lung, and Blood Institute, the National Institute on Aging, and the Doris Duke Charitable Foundation. The team says their next step is getting the technology integrated into frontline clinics globally.
Why it matters
For patients, this could turn every routine checkup into an early warning system. Catching heart failure years before symptoms appear means doctors can start lifestyle interventions or prescribe protective medications early, keeping people out of hospital beds.
For the health tech industry, Yale's decision to feed the model plain photos is the smartest move here. Instead of forcing clinics to upgrade legacy software or build complex API pipelines to export raw DICOM files, any clinician with a camera can theoretically run the tool. That opens the door for low-resource clinics where advanced diagnostic equipment simply doesn't exist.
We think this pragmatic approach is how AI actually reaches global scale: maximize the utility of existing, dirt-cheap infrastructure rather than inventing expensive new tests.
That said, relying on image recognition carries obvious real-world risks. Crumpled paper, bad lighting, glare, or awkward camera angles could throw off predictions. More importantly, flagging someone as high-risk is only half the battle. Healthcare systems will need clear, validated treatment protocols to manage asymptomatic, high-risk patients without triggering a wave of unnecessary panic or overmedication.
Sources (1)
- medicine.yale.edu(opens in a new tab)Originalmedicine.yale.edu